Drugs / Dehydrated Alcohol Injection, USP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07083765 | Sep 2025 → Jun 2027 | essential hypertension | Ablative Solutions, Inc. | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dehydrated Alcohol Injection, USP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07083765 ↗ |